Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF. | Int J Mol Sci | 2021 | 34360799 | PubTator, text mining | PubMed |
| Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2021 | 34359706 | PubTator, text mining | PubMed |
| Genetic Investigation of Inverse Psoriasis. | Life (Basel) | 2021 | 34357026 | PubTator, text mining | PubMed |
| Infant processed food consumption and their interaction to breastfeeding and growth in children up to six months old. | BMC Public Health | 2021 | 34353303 | PubTator, text mining | PubMed |
| A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer. | Mol Carcinog | 2021 | 34347914 | PubTator, text mining | PubMed |
| Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland. | Breast Cancer Res | 2021 | 34344445 | PubTator, text mining | PubMed |
| Genetic Polymorphisms of Long Non-coding RNA Linc00312 Are Associated With Susceptibility and Predict Poor Survival of Nasopharyngeal Carcinoma. | Front Cell Dev Biol | 2021 | 34336850 | PubTator, text mining | PubMed |
| Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma. | Front Cell Dev Biol | 2021 | 34336826 | PubTator, text mining | PubMed |
| Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression. | Cancer Discov | 2021 | 34330779 | PubTator, text mining | PubMed |
| Structural Brain Changes Associated with Overweight and Obesity. | J Obes | 2021 | 34327017 | PubTator, text mining | PubMed |
| Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma. | Cancers (Basel) | 2021 | 34298847 | PubTator, text mining | PubMed |
| HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia. | Front Oncol | 2021 | 34295818 | PubTator, text mining | PubMed |
| Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. | PLoS One | 2021 | 34292953 | PubTator, text mining | PubMed |
| Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition. | Sci Rep | 2021 | 34290314 | PubTator, text mining | PubMed |
| Splicing in the Diagnosis of Rare Disease: Advances and Challenges. | Front Genet | 2021 | 34276790 | PubTator, text mining | PubMed |
| Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis. | Bioengineered | 2021 | 34261404 | PubTator, text mining | PubMed |
| A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases. | Sci Rep | 2021 | 34253785 | PubTator, text mining | PubMed |
| Anesthetic management of multiple acyl-coenzyme A dehydrogenase deficiency in a series of surgeries under general anesthesia: a case report. | JA Clin Rep | 2021 | 34245397 | PubTator, text mining | PubMed |
| Targeted therapy in advanced non-small cell lung cancer: current advances and future trends. | J Hematol Oncol | 2021 | 34238332 | PubTator, text mining | PubMed |
| The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? | Int J Mol Sci | 2021 | 34207825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=24